AlphaVax

AlphaVax has developed a series of vaccine products for infectious diseases, biodefense, and cancer. It uses the alphavaccine vector platform technology to generate a series of candidate vaccines for the prevention of infectious diseases and cancer immunotherapy. AlphaVax was founded by Jonathan F. Smith and is headquartered in Durham, North Carolina.